Live Chat Software

Additional Content Download

Video: A Spotlight On Our Sponsors

Video: A Spotlight On Our Sponsors

The Cold Chain Global Forum is the largest exhibition of solutions and services for temperature controlled life science products. Don't just take our word for it - see and hear it for yourself, we guarantee you'll be impressed.

Temperature Controlled Supply Interview

Temperature Controlled Supply Interview

Join Gilles Jr. Gregoire, Global Transport Manager, Pharmascience as he discusses topics that include; the 3 biggest cold chain packaging trends of 2017, real time temp monitoring technologies, the growing trend towards “direct to patient” deliveries and much more.

Data Sharing and Temp Monitoring Tech

Data Sharing and Temp Monitoring Tech

Join Claude Jolicoeur, Director of Regulatory Affairs, McKesson Canada Corp as he discusses topics that include; changes within the supply chian industry on capturring and shareing data, real time temp monitoring technologies,cold chain challenges wihtin the Canadian market and much more.

Switch from Air to Ocean

Switch from Air to Ocean

Join Andrea L. Guisbert-Williams, Project Manager, North American Logistics Operations, Eli Lilly & Company in an exclusive interview about the effect of growth of biologic based products on temp controlled operations, next generation medicines, and her case study, Discovering Eli Lilly’s Plan to Achieve Cost Savings & Sustainability Through a Switch from Air to Ocean.

Content Pack: Top Industry Content

Content Pack: Top Industry Content

For the 15th Annual Global Forum, we re-released some of the most well received industry content from 2016's event.

Take a look at our Global Forum Content Pack or request an emailed copy that includes:

  • In-depth report on "Standardization and Risk Management in the Cold Chain"
  • Best Practice Guidebook for "Packaging Design & Qualification in Temperature Controlled Logistics"
  • Global Mastery eBook featuring interviews with Eli Lilly, Amgen, McKesson, Novartis LatAm and many more

Email enquiry@iqpc.com to request an emailed copy.

Digitization and Big Data's Impact

Digitization and Big Data's Impact

Pharma and biotech companies are implementing new technologies to enhance how they make decisions and predict outcomes in the supply chain.
Whitepaper: Insights from the Experts

Whitepaper: Insights from the Experts

It's an innovative time in the industry as new technologies are changing the supply chain and business are trying to find new ways to get their products where they need to be faster, more efficiently while saving money. See what executives from Merck, Amgen, Zogenix, Marketing Association, Eli Lilly, GlaxoSmithKline and more are saying about the current state of the industry, future trends, and what they look forward to most about the Global Forum.
Supplying Next Generation Medicines

Supplying Next Generation Medicines

The personalized medicines market – which tailors drugs and treatments to the individual patient – is expected to reach revenues of $149 billion by 2020, according to Pharmaceutical Commerce. And the rising use of biosimilars – a biologic medical product that is a near-identical copy of an original product by another company – is expected to result in the near doubling of the size of pharma cold chain logistics business over the next three years. We sat down with Catherine Coppage, Supply Chain Planner, Personalized Medicines at Kiadis Pharma; Javier Gomez-Contreras, Supply Chain BGx LATAMOE Latina-Mid East Africa-India & Asia Pacific Lead at GlaxoSmithKline; and Jeremy Cress, Director Of Operations, Fibrocell Science to dive into the challenges and opportunities distributing personalized medicines present.
End-to-End Supply Chain Visibility

End-to-End Supply Chain Visibility

The Associate Director of Supply Chain Management at Merck gives us deeper dive into end-to-end supply chain visibility in this white paper.
CRT Requirement in Pharma Distribution

CRT Requirement in Pharma Distribution

Pelican BioThermal was a participating sponsor of the 15th Annual Global Forum. Read their white paper here.
Moving Towards Collaboration Whitepaper

Moving Towards Collaboration Whitepaper

Collaboration has long been considered an effective approach and is employed by many highfunctioning organizations. In business and in communities, the strategic value of aligning yourself with other groups that have a shared vision, where each collaborator brings something to the table and is willing to work together to get there is now seen. Collaboration between different groups - within and outside the enterprise – makes for a changed dynamic. It is a commonly held view that stakeholders in collaboration are at their best, fully invested and engaged, even if conflict situations arise. This whitepaper dives into how collaboration is effective for the pharmaceutical supply chain industry.
Disruption in the Pharma Industry

Disruption in the Pharma Industry

What will technologies will disrupt the life sciences supply chain industry in 2018? To find out, we sat down with Paul Zikopoulos, VP of Competitive and Big Data Analytics Teams and Future Trends Expert, IBM, and the 2017 Global Forum's keynote speaker.

IBM Breakthrough May Help Beat Cancer

IBM Breakthrough May Help Beat Cancer

The 2017 Keynote Speaker, Paul Zikopoulous, VP Big Data & Cognitive Systems at IBM, shared with us this Bloomberg clip of IBM Watson and how it may help beat cancer. This was a focus of Paul's keynote session "The Big Data Revolution" at the 15th Annual Global Forum. View the news clip & get a preview of what Paul discussed in Chicago!
Clinical Trial Supply 2018 Report: The Quest To Shrink Wastage Levels

Clinical Trial Supply 2018 Report: The Quest To Shrink Wastage Levels

In meeting the growth ahead for clinical trials there must be a focus on efficiency as their supply already suffers from major issues with wastage levels. This is lack of control is problematic with the rising public scrutiny on spending by pharmaceutical companies.

Forecasting and demand planning

When sites are under supplied, sponsors may be forced to halt enrolment or even freeze patient treatments. This could have a large influence on the outcomes of a trial. Due to a range of factors, study design, patient enrolment, quantity of sites, site location, that can suddenly change the level of supplies needed for a trial to run, supply managers reduce the risk of stock outs by supplying a surplus of medicine. This in many cases spills over to become overage – when the investigational medicines have to be wasted at the end of a trial or hit their expiry dates before consumption.

The Benefits of Blockchain: Fact or Wishful Thinking?

The Benefits of Blockchain: Fact or Wishful Thinking?

The basics: Blockchain is still a largely unproven innovation in the supply chain, but it’s also one that companies can’t afford to ignore. This first part of four in this issue of NextGen Supply Chain details what the technology is and how it works to make the supply chain more effective.
NextGen Supply Chain: The Robots are Here

NextGen Supply Chain: The Robots are Here

Long a fixture on the factory floor, a new generation of robots are ready for a broader range of applications. The only thing standing in their way is end-user adoption.
8 Fundamentals for Achieving AI Success in the Supply Chain

8 Fundamentals for Achieving AI Success in the Supply Chain

In the race to use AI, many companies have made attempts to implement it, but the results have been disappointing.

Meet Our Keynote: Tom Bonkenburg

Tom Bonkenburg is a partner in St. Onge Company, an international supply chain engineering and consulting firm. Since its founding in 1983, St. Onge Company has preformed over 4000 assignments for over 700 clients in over 40 countries and now has offices in the US, Europe, Middle East, and Asia.

Mr. Bonkenburg will discuss the latest available robotic technology, talk about the companies that are using this technology, and what the supply chain professional needs to know now about the possible future impact of this rapidly developing industry.

Autonomous Supply Chain is Coming

Autonomous Supply Chain is Coming

A Conversation with Tom Bonkenburg Director, European Operations, St. Onge Company where he shares why you can't afford to fall behind the pharma supply chain robotics revoloution.

Infographic: A Guide to Reducing Your Shipping Costs

Infographic: A Guide to Reducing Your Shipping Costs

While base rates stand as the bulk of shipping and freight costs, accessorial fees can cause a significant increase in the total expense. Learn about some of the most common accessorial fees, the influence they can have on your supply chain and how to reduce or avoid them.

Download this infographic and use as a resource to slash your shipping costs.

Areas covered:

  • What’s what: Definitions of the fees to expect within shipping regarding weight and density, additional fees and origin vs destination.
  • Tips and tricks: On how to best minimize these fees and acquire savings.
Blockchain Adoption in Pharma Supply Whitepaper

Blockchain Adoption in Pharma Supply Whitepaper

Experts have asserted that despite recent developments, pharmaceutical supply chains are still far from reaching their full technological potential. However, Blockchain holds significant promise to advance the digital strength of medicine supply. In this whitepaper, we explore:

  •  What is blockchain and how can it be applied to cold chain?
  • Who in life sciences is currently using blockchain and for what?
  • How will the emergence of blockchain impact the industry over the next decade?

Plus! We provide an overview of potential use cases for block chain such as:

  • Leveraging R&D data for collaborative research
  • Dynamic pricing managed for raw materials
  • Compliance and quality tracking
  • Pharmacovigilance reporting
  • Temperature control
  • Temperature monitoring and control

Serialization: Avoid these risks in the race to compliance deadlines

Serialization: Avoid these risks in the race to compliance deadlines

Serialization is set to revolutionize how business is done in pharma. It is a complex technical project involving engineering systems at line, distribution operation levels and enterprise IT systems, at site and global levels.

Coming back to today’s reality, and despite the years given for implementation, observers will be aware that a vast portion of the manufacturing landscape is behind schedule and is now scrambling to meet international compliance deadlines.

Download this whitepaper to discover:

  • Golden rules for serialization projects
  • The organizational and technical challenges that creep into serialization projects
  • The dangers of leaving implementation too late
  • How serialization powers pharma's digital transformation